Daniela Maria Cirillo

Unusual mycobacterial interspersed repetitive-unit alleles in loci 580 and 4348 among Mycobacterium tuberculosis isolates in Albania.

Epidemic MRSA clone ST22-IV is more resistant to multiple host- and environment-related stresses compared with ST228-I.

Target product profile of a molecular drug-susceptibility test for use in microscopy centers.

Universal health coverage and social support in Senegal: a comprehensive approach against tuberculosis.

Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype.

Implementation of a Consensus Set of Hypervariable Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Loci in Mycobacterium tuberculosis Molecular Epidemiology.

Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Preliminary data on precision of QuantiFERON-TB Plus performance.

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.

From latent to patent: rethinking prediction of tuberculosis.

Mycobacterium aquaticum sp. nov., a rapidly growing species isolated from haemodialysis water.

Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature.

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey.

EUSeqMyTB to set standards and build capacity for whole genome sequencing for tuberculosis in the EU.

Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries.

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update.

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.

A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis.

Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.

Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis.

Implementing TB control in a rural, resource-limited setting: the stop-TB Italia project in Senegal.

MTBseq: a comprehensive pipeline for whole genome sequence analysis of complex isolates.

ASAP-GxNet project in Burkina Faso: fulfil country capacity gaps to ensure efficient utilisation of GeneXpert instruments in tuberculosis care and cascade.

Hospital outbreak due to Clostridium difficile ribotype 018 (RT018) in Southern Germany.

Lack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis.

Isoniazid Resistance in Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms.

Emergence of two novel sequence types (3366 and 3367) NDM-1- and OXA-48-co-producing K. pneumoniae in Italy.

App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis.

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.

Corrigendum: Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of .

Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.

Whole genome sequencing in .

Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis cases.

Treating Primary Arthroprosthesis Infection Caused by subsp. a.

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.

EasyPrimer: user-friendly tool for pan-PCR/HRM primers design. Development of an HRM protocol on wzi gene for fast Klebsiella pneumoniae typing.

Accuracy of the QIAxcel Automated System for MIRU-VNTR Genotyping of in Two Limited Resource Settings.

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of from Iran.

Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic.

Comparison of core-genome MLST, coreSNP and PFGE methods for cluster analysis.

Celebrating World Tuberculosis Day at the time of COVID-19.

Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples.

Use of a whole genome sequencing-based approach for surveillance in Europe in 2017-2019: an ECDC pilot study.

Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.

What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection.

Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS-CoV-2 positivity.

Advantages and Challenges of Tailored Regimens for Drug-Resistant Tuberculosis: A StopTB Italia Look into the Future.

The neglected role of Faith-based Organizations in prevention and control of COVID-19 in Africa.

Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains.

A New Model of Chronic Lung Infection in Immunocompetent Mice.

Genomic analysis of cardiac surgery-associated Mycobacterium chimaera infections in Italy.

Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients.

Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy.

Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.

Applying a Standardized Approach to Strengthen Performances of GeneXpert Networks programme: lessons learned from Burkina Faso, 2019.

Repeatability and reproducibility of the wzi high resolution melting-based clustering analysis for Klebsiella pneumoniae typing.

Framework for the evaluation of new tests for tuberculosis infection.

Tackling TB in migrants arriving at Europe's southern border.

Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in Tunisia.

Integrative transnational analysis to dissect tuberculosis transmission events along the migratory route from Africa to Europe.

Is deployement of diagnostic test alone enough? Comprehensive package of interventions to strengthen TB laboratory network: three years of experience in Burkina Faso.

Tests for tuberculosis infection: landscape analysis.

Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.

Outbreak of pre- and extensively drug-resistant tuberculosis in northern Italy: urgency of cross-border, multidimensional, surveillance systems.

A PGE-MEF2A axis enables context-dependent control of inflammatory gene expression.

Is the new WHO definition of extensively drug-resistant tuberculosis easy to apply in practice?

Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.

Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy.

Population structure, biogeography and transmissibility of Mycobacterium tuberculosis.

QIAreach QuantiFERON-TB for the diagnosis of infection.

microevolution of and transient emergence of _Ala63Pro mutation during treatment in a pre-XDR TB patient.

Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological study.

Detection of NDM-1/5 and OXA-48 co-producing extensively drug-resistant hypervirulent Klebsiella pneumoniae in Northern Italy.

Whole genome sequencing of isoniazid monoresistant clinical isolates of Mycobacterium tuberculosis reveals novel genetic polymorphisms.

Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes.

Utility of the Whole Genome Sequencing based methodologies in routine European tuberculosis reference laboratory network setting.

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.

The 2021 WHO catalogue of complex mutations associated with drug resistance: A genotypic analysis.

Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020.

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history.

Fragmentation of Healthcare Services as a Possible Determinant of the Low Completion for the Tuberculosis Cascade of Prevention among Asylum Seekers: Results from a Prospective Study with Historical Comparison.

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape.

Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.

Hypervariable-Locus Melting Typing: a Novel Approach for More Effective High-Resolution Melting-Based Typing, Suitable for Large Microbiological Surveillance Programs.

Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches.

Genomic features of in vitro selected mutants of Escherichia coli with decreased susceptibility to tigecycline.

Improving interferon-γ release assay interpretation: are IP-10 and MIG the solution?

Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region: Action is Needed by all Member States.

Balancing access to BPaLM regimens and risk of resistance.

Whole genome sequencing of Bulgarian rifampicin resistant strains.

Transcriptional regulation and drug resistance in .

Designing molecular diagnostics for current tuberculosis drug regimens.

Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.

Advantages of long- and short-reads sequencing for the hybrid investigation of the genome.

Whole-genome sequence analysis of clinically isolated carbapenem resistant Escherichia coli from Iran.

Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries.

Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience.

The effect of lineage on clinical phenotype.

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.

Screening for Tuberculosis Infection among Migrants: A Cost-Effectiveness Analysis in the Italian Context.

Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on Strains by Whole-Genome Sequencing.

Appeal from the European tuberculosis reference laboratory network (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria.

Mind the gap. Rolling out new drug resistant tuberculosis regimens with limited diagnostic tools.

Update on the diagnosis of tuberculosis.

Rolling out new anti-tuberculosis drugs without diagnostic capacity.

Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series.

The small non-coding RNA B11 regulates multiple facets of Mycobacterium abscessus virulence.

Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings: a programmatic model, challenges, and initial outcomes.

Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGS.

Tuberculosis incidence in foreign-born people residing in European countries in 2020.

A smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex.

Tuberculosis in Ukrainian War Refugees and Migrants in the Czech Republic and Slovakia: A Molecular Epidemiological Study.

The effect of M. tuberculosis lineage on clinical phenotype.

Cultivation and sequencing-free protocol for detection and typing.

Characteristic SNPs defining the major multidrug-resistant clusters identified by EuSeqMyTB to support routine surveillance, EU/EEA, 2017 to 2019.

Multidrug-resistant tuberculosis.

Transcriptomic responses to antibiotic exposure in .

Genetic barriers more than environmental associations explain Serratia marcescens population structure.

Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al.

The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division.

Long-term successfull management of recurrent episodes of nontuberculous mycobacterial infection in an apparently healthy Chinese woman.

Targeted next-generation sequencing of from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh.

Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies.

Infection with extensively drug-resistant harbouring in a gay man in Italy.

Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs.

Whole-genome sequencing-based characterization of Salmonella enterica Serovar Enteritidis and Kentucky isolated from laying hens in northwest of Iran, 2022-2023.

Four months daily rifampicin vs. 3 months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trial.

Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis.

Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across Italy.